Tarsons Products Limited's (NSE:TARSONS) Popularity With Investors Is Clear
Jul 30
Indian (NIFTY) Life Sciences Industry Analysis
UpdatedAug 02, 2024
DataAggregated Company Financials
Companies16
- 7D6.3%
- 3M22.9%
- 1Y25.5%
- YTD23.9%
In the last week, the Life Sciences industry is up 7.8%, with Divi's Laboratories up 8.2%. This means that the industry has gained 26% over the past year. Looking forward, earnings are forecast to grow by 20% annually.
Industry Valuation and Performance
Has the Indian Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 02 Aug 2024 | ₹1.9t | ₹201.7b | ₹23.8b | 39.2x | 81.9x | 9.6x |
| Sun, 30 Jun 2024 | ₹1.8t | ₹198.0b | ₹23.7b | 33.8x | 74.5x | 8.9x |
| Tue, 28 May 2024 | ₹1.6t | ₹193.7b | ₹21.6b | 34.3x | 76.1x | 8.5x |
| Thu, 25 Apr 2024 | ₹1.4t | ₹168.5b | ₹18.6b | 30x | 76.9x | 8.5x |
| Sat, 23 Mar 2024 | ₹1.3t | ₹168.5b | ₹18.6b | 28.8x | 71.1x | 7.8x |
| Mon, 19 Feb 2024 | ₹1.4t | ₹168.5b | ₹18.6b | 31.1x | 77.1x | 8.5x |
| Wed, 17 Jan 2024 | ₹1.4t | ₹165.1b | ₹18.8b | 32.9x | 76.6x | 8.7x |
| Fri, 15 Dec 2023 | ₹1.3t | ₹155.9b | ₹18.1b | 22x | 74.6x | 8.6x |
| Sun, 12 Nov 2023 | ₹1.3t | ₹156.4b | ₹18.1b | 21.4x | 72x | 8.4x |
| Tue, 10 Oct 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 25x | 70.4x | 9x |
| Thu, 07 Sep 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 26.4x | 71.8x | 9.1x |
| Sat, 05 Aug 2023 | ₹1.4t | ₹158.1b | ₹23.2b | 30.1x | 60.7x | 8.9x |
| Mon, 03 Jul 2023 | ₹1.3t | ₹157.2b | ₹23.0b | 29.2x | 58.3x | 8.5x |
| Wed, 31 May 2023 | ₹1.3t | ₹157.7b | ₹22.6b | 37.7x | 56.8x | 8.1x |
| Fri, 28 Apr 2023 | ₹1.2t | ₹162.6b | ₹28.7b | 33.1x | 41.8x | 7.4x |
| Sun, 26 Mar 2023 | ₹1.0t | ₹159.5b | ₹28.4b | 31.1x | 37x | 6.6x |
| Tue, 21 Feb 2023 | ₹1.1t | ₹159.5b | ₹28.4b | 32.1x | 37.8x | 6.7x |
| Thu, 19 Jan 2023 | ₹1.2t | ₹164.9b | ₹34.5b | 30.1x | 35.6x | 7.4x |
| Sat, 17 Dec 2022 | ₹1.2t | ₹164.9b | ₹34.5b | 29.5x | 34.8x | 7.3x |
| Mon, 14 Nov 2022 | ₹1.2t | ₹164.4b | ₹34.8b | 29.7x | 34.4x | 7.3x |
| Wed, 12 Oct 2022 | ₹1.2t | ₹162.5b | ₹35.7b | 35.1x | 34.7x | 7.6x |
| Fri, 09 Sep 2022 | ₹1.3t | ₹162.6b | ₹35.8b | 46.6x | 35.5x | 7.8x |
| Sun, 07 Aug 2022 | ₹1.4t | ₹159.1b | ₹34.5b | 35.1x | 39.4x | 8.5x |
| Tue, 05 Jul 2022 | ₹1.3t | ₹158.3b | ₹34.2b | 32.6x | 37.3x | 8.1x |
| Thu, 02 Jun 2022 | ₹1.3t | ₹158.2b | ₹34.1b | 31.9x | 36.7x | 7.9x |
| Sat, 30 Apr 2022 | ₹1.5t | ₹123.2b | ₹29.2b | 35.6x | 52.7x | 12.5x |
| Mon, 28 Mar 2022 | ₹1.5t | ₹148.3b | ₹29.4b | 34.4x | 51.7x | 10.2x |
| Wed, 23 Feb 2022 | ₹1.4t | ₹148.3b | ₹29.4b | 19.9x | 49.3x | 9.8x |
| Fri, 21 Jan 2022 | ₹1.5t | ₹137.8b | ₹24.6b | 44.3x | 61.5x | 11x |
| Sun, 19 Dec 2021 | ₹1.5t | ₹137.8b | ₹24.6b | 31.4x | 62.5x | 11.2x |
| Tue, 16 Nov 2021 | ₹1.6t | ₹135.3b | ₹23.7b | 27.8x | 68.3x | 12x |
| Thu, 14 Oct 2021 | ₹1.7t | ₹131.1b | ₹22.9b | 22x | 75.3x | 13.2x |
| Sat, 11 Sep 2021 | ₹1.7t | ₹131.1b | ₹22.9b | 24.5x | 72.8x | 12.7x |
| Mon, 09 Aug 2021 | ₹1.6t | ₹127.1b | ₹22.6b | 40x | 71.6x | 12.7x |
Price to Earnings Ratio
71.6x
Current Industry PE
- Investors are optimistic on the Indian Life Sciences industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 81.9x which is higher than its 3-year average PE of 57.4x.
- The industry is trading close to its 3-year average PS ratio of 9.0x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 17% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Indian Healthcare industry?
| IN Market | 2.59% | |
| Healthcare | 3.08% | |
| Life Sciences | 6.26% | |
| Clinical Research and Equipment | 6.26% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DIVISLAB Divi's Laboratories | ₹4.92k | 8.2% +₹98.5b | 32.0% | PE81.6x | |
| SYNGENE Syngene International | ₹828.50 | 5.3% +₹16.7b | 3.7% | PE67.5x | |
| DCAL Dishman Carbogen Amcis | ₹190.75 | 12.9% +₹3.4b | 19.2% | PS1.1x | |
| WINDLAS Windlas Biotech | ₹807.00 | 11.0% +₹1.7b | 146.9% | PE29x | |
| 530239 Suven Life Sciences | ₹143.05 | 1.3% +₹403.4m | 129.2% | PS266.8x |